Monitoring blood flow in the brain after a stroke caused by an aneurysm.
Noninvasive monitoring of cerebrovascular regulation in subarachnoid hemorrhage.
This study is looking at ways to help people who have had a specific type of stroke called aSAH by using a new tool to keep an eye on blood flow in the brain, so doctors can quickly spot any problems and take action to help prevent serious complications.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of South Florida NIH-funded |
| Lab location | 1 site (Tampa, United States) |
| Project ID | NIH-11000302 on NIH RePORTER |
What this research studies
This research focuses on patients who have experienced an aneurysmal subarachnoid hemorrhage (aSAH), a type of stroke caused by the rupture of an intracranial aneurysm. The study aims to develop a noninvasive method to continuously monitor brain blood flow and identify patients at risk for delayed cerebral ischemia (DCI), a serious complication that can lead to poor outcomes. By using a novel optical instrument called Pathlength Resolved Diffuse Correlation Spectroscopy (PR-DCS), researchers hope to provide real-time data that can help clinicians make timely interventions. This approach seeks to improve patient management and outcomes following aSAH.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have recently suffered an aneurysmal subarachnoid hemorrhage.
Not a fit: Patients who have not experienced aSAH or those with other unrelated neurological conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better monitoring and treatment strategies for patients recovering from aSAH, potentially reducing the incidence of serious complications.
How similar studies have performed: Previous research has shown promise in using noninvasive monitoring techniques for cerebrovascular conditions, suggesting potential success for this novel approach.
Where this research is happening
Tampa, United States
- University of South Florida — Tampa, United States (Active)
Researchers
- Principal investigator: Mokin, Maxim — University of South Florida
- Study coordinator: Mokin, Maxim
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.